Biosimilars and Biobetters Conference 2017

SMi Group present the 2017 8th annual event on Biosimilars & Biobetters, taking place on 27-28 Sept in London, UK. As the patents for several innovator biologics expire, biopharmaceutical companies are taking the opportunity to develop more affordable forms creating a rapidly booming biosimilars market. However, as the field of biosimilars evolves, challenges in immunogenicity studies, securing market share, exclusivity and regulations still persist. Join us this autumn to arm yourself with the key requirements and tools for successful market entry through strategic direction on commercialisation; insight into potential therapeutic areas; and critical updates on interchangeability guidelines and patient litigation. FEATURED SPEAKERS: Bernd Liedert, Snr Clinical Program Leader Biosimilars, Boehringer Ingelheim Ho-Ung Kim, Division Head Strategy & Operations, Celltrion Healthcare Sarah Rickwood, VP, Head of European Thought Leadership, QuintilesIMS Matthew Turner, Global Medical Dir, Biosimilars, Merck Group Steiner Madsen, Medical Dir, Norwegian Medicines Agency Thomas Sachnik, Snr Manager Strategic Associate to the President & CEO Generics Europe, and many more...